SAVA Cassava Sciences, Inc. Stock Quote

SAVA [NASD]

Index	-	P/E	-	EPS (ttm)	-0.55	Insider Own	1.90%	Shs Outstand	39.96M	Perf Week	15.52%
Market Cap	2.04B	Forward P/E	-	EPS next Y	-0.60	Insider Trans	0.00%	Shs Float	37.46M	Perf Month	25.44%
Income	-20.80M	PEG	-	EPS next Q	-0.33	Inst Own	30.00%	Short Float	30.30%	Perf Quarter	-4.08%
Sales	-	P/S	-	EPS this Y	8.80%	Inst Trans	10.37%	Short Ratio	1.32	Perf Half Y	3.78%
Book/sh	6.70	P/B	8.35	EPS next Y	25.40%	ROA	-8.90%	Target Price	159.25	Perf Year	626.75%
Cash/sh	6.63	P/C	8.44	EPS next 5Y	-	ROE	-9.10%	52W Range	6.70 - 146.16	Perf YTD	720.53%
Dividend	-	P/FCF	-	EPS past 5Y	35.40%	ROI	-	52W High	-61.71%	Beta	0.51
Dividend %	-	Quick Ratio	39.80	Sales past 5Y	-	Gross Margin	-	52W Low	735.22%	ATR	8.03
Employees	11	Current Ratio	39.80	Sales Q/Q	-	Oper. Margin	-	RSI (14)	47.76	Volatility	11.52% 16.30%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-317.90%	Profit Margin	-	Rel Volume	0.22	Prev Close	58.05
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	8.63M	Price	55.96
Recom	2.00	SMA20	-9.49%	SMA50	-1.09%	SMA200	-11.48%	Volume	1,937,628	Change	-3.60%

Jul-15-21

Downgrade

Cantor Fitzgerald

Overweight → Neutral

$100

Jul-07-21

Reiterated

Maxim Group

Buy

$80 → $190

Apr-27-21

Initiated

B. Riley Securities

Buy

$78

Feb-16-21

Reiterated

H.C. Wainwright

Buy

$20 → $66

Oct-23-20

Initiated

Cantor Fitzgerald

Overweight

$24

Sep-23-20

Upgrade

H.C. Wainwright

Neutral → Buy

$20

May-18-20

Downgrade

H.C. Wainwright

Buy → Neutral

May-15-20

Downgrade

Maxim Group

Buy → Hold

Jan-10-20

Reiterated

Maxim Group

Buy

$3 → $12

Nov-27-21 01:18PM	10 Meme Stocks that More than Doubled in 2021 Insider Monkey
Nov-26-21 09:34AM	Is the Options Market Predicting a Spike in Cassava Sciences (SAVA) Stock? Zacks
Nov-22-21 11:00AM	Cassava Sciences Just Returned to the Buy Zone InvestorPlace
Nov-19-21 08:59AM	Cassava Sciences faces increased scrutiny of Alzheimer's drug, presses ahead with advanced trials American City Business Journals +9.81%
Nov-18-21 02:27PM	Cassava Sciences Kickstarts Second Late-Stage Alzheimer's Trial With Simufilam Benzinga
10:36AM	Biogen's (BIIB) Aducanumab Gets CHMP's Negative Trend Vote Zacks
09:15AM	Cassava Sciences Initiates a Second Phase 3 Study of Simufilam for the Treatment of Patients with Alzheimers Disease GlobeNewswire
08:43AM	Cassava (SAVA) Down on Report of SEC Investigation Into AD Program Zacks
06:04AM	3 Biotech Stocks That Have More Than Tripled so far This Year Motley Fool
Nov-17-21 04:55PM	SEC Investigating Cassava Sciences, Developer of Experimental Alzheimers Drug The Wall Street Journal -23.70%
04:40PM	CASSAVA SCIENCES INC. INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Cassava Sciences Inc. GlobeNewswire
04:04PM	Cassava Sciences In Hot Water Again As Shorts Claim 'Extreme' Data Manipulation Investor's Business Daily
02:27PM	See Why Cassava Sciences Shares Are Falling On Wednesday? Benzinga
01:14PM	Why Cassava Sciences Is Sliding Lower Today Motley Fool
09:32AM	Cassava Shares Drop Following Report of SEC Investigation Bloomberg
08:12AM	Cassava Sciences Stock Tumbles on News of SEC Investigation TheStreet.com
08:00AM	5 Top Stock Decliners for Wednesday Feel Inflation Pinch TheStreet.com
04:53AM	Cassava Slumps on Report SEC Probing Developer of Alzheimers Drug Investing.com
Nov-15-21 11:33AM	10 Reddit Stocks to Buy in November Insider Monkey -12.05%
09:00AM	Cassava Sciences CEO addresses hurdles, high points while chasing Alzheimer's breakthrough American City Business Journals
Nov-11-21 04:08PM	Cassava And Cortexyme Diverge Why One Alzheimer's Stock Is 'Back On Track' Investor's Business Daily
12:11PM	7 Short-Squeeze Stocks Loaded With High-Risk, High-Reward Upside InvestorPlace
07:44AM	The Zacks Analyst Blog Highlights: Regeneron, Moderna, Cassava Sciences, Biohaven Pharma and Pfizer Zacks
Nov-10-21 12:53PM	Biotech Stock Roundup: REGN, MRNA Post Q3 Earnings, SAVA Gains on AD Review Data Zacks -11.49%
09:00AM	Cassava Sciences Reports Third Quarter 2021 Financial Results GlobeNewswire
Nov-09-21 09:40PM	Cassava: A Controversial Top Pick TipRanks -12.38%
11:51AM	Cassava Sciences Needs Time and Data to Prove Itself Before You Buy InvestorPlace
09:16AM	Cassava Is a Sell After Accusations of Data Manipulation InvestorPlace
Nov-04-21 05:24PM	Why Did Cassava Sciences Stock Jump 49% Today? Benzinga +48.96%
04:01PM	Cassava Stock Soars; Journal Finds No Proof Of Tampered Alzheimer's Data Investor's Business Daily
02:04PM	Why Cassava Sciences Shares Are Rising Benzinga
09:30AM	Review by Journal of Neuroscience Shows No Evidence of Data Manipulation in Technical Paper Foundational to Cassava Sciences Lead Drug Candidate GlobeNewswire
09:02AM	Cassava Stock Soars; Review Finds 'No Evidence of Manipulation' TheStreet.com
06:38AM	Cassava Soars as Journal of Neuroscience Backs it on Alzheimers Study Investing.com
Nov-03-21 03:08PM	Cassava Sciences Is on a Bumpy Road to Multibagger Status InvestorPlace
Nov-02-21 09:00PM	Bragar Eagel & Squire is Investigating Certain Officers and Directors of CarLotz, HyreCar, Cassava, and Katapult on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm GlobeNewswire +25.94%
Nov-01-21 11:32AM	Cassava Sciences (SAVA) to Post Q3 Earnings: What's in Store? Zacks +6.91%
06:00AM	Cassava Stock Could Jump More Than 200 Times InvestorPlace
06:00AM	Cassava Sciences Stock Remains an Enigma InvestorPlace
Oct-29-21 04:34PM	Buy SAVA Stock on Dips as its Phase 3 Trial Moves Along InvestorPlace
02:30PM	SHAREHOLDER ALERT: Robbins LLP Investigates Cassava Sciences, Inc. (SAVA) on Behalf of Shareholders Business Wire
Oct-28-21 05:45PM	Cassava Sciences, Inc. (SAVA) Stock Sinks As Market Gains: What You Should Know Zacks
Oct-26-21 07:46PM	SAVA CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Cassava Sciences, Inc. Business Wire
05:50PM	Cassava Sciences, Inc. (SAVA) Stock Sinks As Market Gains: What You Should Know Zacks
02:40PM	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Cassava Sciences, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 26, 2021 - (SAVA) Newsfile
01:10PM	FINAL DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Cassava Sciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
12:05PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Cassava Sciences, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 26, 2021 - SAVA Newsfile
10:30AM	The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Cassava Sciences, Inc. (SAVA) Business Wire
10:00AM	Final Hours to Actively Participate in Cassava Sciences, Inc. (SAVA) Class Action: Bronstein, Gewirtz & Grossman, LLC Newsfile
09:57AM	SAVA Final Deadline Today: Rosen, Trusted Investor Counsel, Encourages Cassava Sciences, Inc. Investors with Losses in Excess of $500K to Secure Counsel Before Important October 26 Deadline in Securities Class Action - SAVA Newsfile
09:15AM	CLASS ACTION UPDATE for KPLT, SAVA and HNST: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
07:45AM	DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Cassava Sciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
05:20AM	SAVA LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Cassava Sciences, Inc. Newsfile
Oct-25-21 11:01PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadline - SAVA PR Newswire
06:18PM	Cassava Deadline Alert Newsfile
05:02PM	SAVA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 26, 2021 in the Class Action Filed on Behalf of Cassava Sciences, Inc. Limited Shareholders Newsfile
04:48PM	CASSAVA SCIENCES 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Cassava Sciences, Inc. - SAVA PR Newswire
03:36PM	CASSAVA SCIENCES DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Cassava Sciences and Encourages Investors to Contact the Firm Business Wire
02:40PM	FINAL DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Cassava Sciences, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm ACCESSWIRE
01:42PM	SAVA FINAL DEADLINE TOMORROW: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Cassava Sciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 26 Deadline in Securities Class Action - SAVA PR Newswire
01:41PM	SAVA DEADLINE ALERT: Hagens Berman Announces that Cassava Sciences (SAVA) Investors with $250K+ Losses Have Opportunity to Lead Class Action Lawsuit, OCT. 26TH DEADLINE Newsfile
12:45PM	LAWSUITS FILED AGAINST KPLT, SAVA and ZEV - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
12:05PM	DEADLINE ALERT for KPLT, HYRE, and SAVA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
11:00AM	Last Day to Actively Participate in Cassava Sciences, Inc. (SAVA) Class Action: Bronstein, Gewirtz & Grossman, LLC Business Wire
09:41AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Cassava Sciences, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 26, 2021 - SAVA Newsfile
08:04AM	DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Cassava Sciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
05:40AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of KPLT, SAVA and INNV ACCESSWIRE
Oct-24-21 11:50PM	FINAL DEADLINE TUESDAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Cassava Sciences, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm ACCESSWIRE
09:20PM	CASSAVA SCIENCES 48 HOUR DEADLINE ALERT: FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Cassava Sciences, Inc. - SAVA ACCESSWIRE
03:09PM	Final Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Cassava Sciences, Inc. GlobeNewswire
01:00PM	SAVA 2-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Cassava Sciences (SAVA) Investors with $250K+ Losses to Contact Firms Attorneys Now, Oct. 26th Deadline in Securities Class Action GlobeNewswire
08:29AM	Cassava Deadline Alert Newsfile
08:29AM	CASSAVA DEADLINE ALERT: Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Cassava To Contact Him Directly To Discuss Their Options GlobeNewswire
08:02AM	(SAVA) DEADLINE: Did You Suffer a Substantial Loss? Contact Johnson Fistel About Leading Cassava Class Action Lawsuit GlobeNewswire
06:34AM	SAVA Final Deadline: ROSEN, A LEADING LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Tuesday Deadline in Securities Class Action SAVA GlobeNewswire
Oct-23-21 06:00PM	SAVA INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Cassava Sciences, Inc. Business Wire
11:15AM	FINAL ALERT: Robbins Geller Rudman & Dowd LLP Announces that Cassava Sciences, Inc. Investors with Significant Losses Have Opportunity to Lead Class Action Lawsuit SAVA GlobeNewswire
11:00AM	TUESDAY DEADLINE: Hagens Berman Announces that Cassava Sciences (SAVA) Investors with $250K+ Losses Have Opportunity to Lead Class Action Lawsuit ACCESSWIRE
09:30AM	SHAREHOLDER ALERT: CASSAVA SCIENCES, INC. (NASDAQ: SAVA) OCTOBER 26, 2021 CLASS ACTION LAWSUIT DEADLINE REMINDER: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Cassava Sciences, Inc. GlobeNewswire
08:03AM	Cassava Update Newsfile
Oct-22-21 10:50PM	CASSAVA SCIENCES 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess Of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Cassava Sciences, Inc. - SAVA Business Wire
10:50PM	APPH, EAR, SAVA, WDH INVESTOR ALERT BY CLAIMSFILER: Pending Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
07:30PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SAVA, EAR and HYZN ACCESSWIRE
05:52PM	Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Class Action Lawsuit Against Cassava Sciences, Inc. (SAVA) Business Wire
04:30PM	INVESTOR ALERT: CASSAVA SCIENCES, INC. (NASDAQ:SAVA) CLASS ACTION LAWSUIT DEADLINE OCTOBER 26, 2021 REMINDER: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Cassava Sciences, Inc. ACCESSWIRE
03:15PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SAVA, EAR and ZEV ACCESSWIRE
02:45PM	DEADLINE TUESDAY NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Cassava Sciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
11:40AM	LAWSUITS FILED AGAINST SAVA, HYRE and SPPI - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
11:30AM	SAVA Investors Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit PR Newswire
11:00AM	SAVA Tuesday Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Cassava Sciences, Inc. Shareholders of Class Action ACCESSWIRE
10:16AM	SAVA 4-DAY DEADLINE ALERT: Hagens Berman Alerts Cassava Sciences (SAVA) Investors to Lead Plaintiff Opportunity in Class Action, Encourages Investors with $250K+ Losses to Contact Firm's Attorneys Now Newsfile
09:15AM	INVESTOR ALERT: CASSAVA SCIENCES, INC. (SAVA) OCTOBER 26, 2021 CLASS ACTION LAWSUIT DEADLINE REMINDER: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Cassava Sciences, Inc. Newsfile
09:00AM	CLASS ACTION UPDATE for SAVA, SPPI and HYZN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
07:50AM	DEADLINE TUESDAY REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Cassava Sciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Oct-21-21 10:35PM	SAM, SAVA SHAREHOLDERS - ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action Lawsuits Filed on Behalf of Investors, Lead Plaintiff Deadlines Set ACCESSWIRE
06:48PM	Cassava Class Action Reminder Newsfile
04:11PM	SAVA DEADLINE NEXT TUESDAY: Robbins Geller Rudman & Dowd LLP Announces that Cassava Sciences, Inc. Investors with Significant Losses Have Opportunity to Lead Class Action Lawsuit ACCESSWIRE
02:44PM	DEADLINE TUESDAY ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Cassava Sciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
12:30PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of KPLT, SAVA and NNOX ACCESSWIRE
10:00AM	SAVA Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Cassava Sciences, Inc. Shareholders of Class Action and October 26, 2021 Deadline GlobeNewswire

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GUSSIN ROBERT Z	Director	Sep 15	Option Exercise	27.37	2,801	76,663	6,710	Sep 21 04:01 PM
BARBIER REMI	President and CEO	Jul 20	Option Exercise	20.23	2,801	56,664	326,652	Jul 20 05:21 PM
BARBIER REMI	President and CEO	May 27	Option Exercise	53.55	56,030	3,000,406	1,134,885	May 28 04:01 PM
ROBERTSON SANFORD	Director	Mar 30	Option Exercise	40.89	7,472	305,521	920,095	Mar 31 09:14 PM
FRIEDMANN NADAV	Chief Medical Officer	Mar 17	Option Exercise	53.55	28,015	1,500,203	92,428	Mar 18 04:06 PM
O DONNELL MICHAEL J	Director	Mar 16	Option Exercise	49.00	4,669	228,781	9,257	Mar 18 03:59 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience